The podcast discusses two documents: the first document is the protocol of a clinical study conducted by Pfizer and BioNTech to evaluate the safety, tolerability, immunogenicity and potential efficacy of RNA vaccines against COVID-19. The second document is a Supply Agreement between the European Commission and Pfizer for the supply of doses of the BNT162b2 vaccine to the member states of the European Union.